Frontiers | What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?
Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation: Cell
Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease | eNeuro
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
IJMS | Free Full-Text | Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats
Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease
The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease
Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease | ACS Chemical Neuroscience
The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease
Microbes and Parkinson's disease: from associations to mechanisms: Trends in Microbiology
Lipopolysaccharide Animal Models for Parkinson's Disease
Is Porphyromonas gingivalis involved in Parkinson's disease? | SpringerLink
Frontiers | Review: The Role of Intestinal Dysbiosis in Parkinson's Disease
Frontiers | The Gut–Brain Axis and Its Relation to Parkinson's Disease: A Review
PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines | ACS Omega
Interleukin-4 Contributes to Degeneration of Dopamine Neurons in the Lipopolysaccharide-treated Substantia Nigra <italic>in vivo</italic>
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
![PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a63c762e0fa3c8d5b24bb90bbf75a3ae3fff0174/6-Figure1-1.png "PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar")